TH and Parkinson disease: In the same Parkinson's disease model, apigenin has been shown to modulate dopaminergic neurotransmission by downregulating α-synuclein expression and enhancing dopamine biosynthesis through the upregulation of dopamine D2 receptor protein expression and tyrosine hydroxylase (Anusha et al., 2017).